We are live on ! Find out more
CSBR icon

Champions Oncology
CSBR

37 hedge funds and large institutions have $100M invested in Champions Oncology in 2018 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 8 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

633% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 3

267% more capital invested

Capital invested by funds: $27.3M → $100M (+$72.7M)

167% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 3

106% more funds holding

Funds holding: 18 → 37 (+19)

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

12.36% more ownership

Funds ownership: 39.08% → 51.44% (+12%)

Holders
37
Holders Change
+19
Holders Change %
+105.56%
% of All Funds
0.85%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
22
Increased
8
Reduced
3
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
EI
EAM Investors
California
+$1.6M
2
Renaissance Technologies
Renaissance Technologies
New York
+$1.47M
3
ISL
Ingalls & Snyder LLC
New York
+$1.41M
4
SSA
Schonfeld Strategic Advisors
New York
+$1.11M
5
JP Morgan Chase
JP Morgan Chase
New York
+$1.1M

Top Sellers

Rank Fund Capital Flow
1
TAM
Tocqueville Asset Management
New York
-$226K
2
EIM
Essex Investment Management
Massachusetts
-$209K
3
Commonwealth Equity Services
Commonwealth Equity Services
Massachusetts
-$76K
4
SSB
Sandy Spring Bank
Maryland
-$53K
5
TRCT
Tower Research Capital (TRC)
New York
-$11K
Name Holding Trade Value Shares
Change 		Change in
Stake
Susquehanna International Group
26
Susquehanna International Group
Pennsylvania
$178K +$91K +10,214 New
Wells Fargo
27
Wells Fargo
California
$96K -$8.9K -1,000 -15%
UBS Group
28
UBS Group
Switzerland
$82K +$27.5K +3,090 +194%
Morgan Stanley
29
Morgan Stanley
New York
$71K +$4.78K +537 +15%
VIMU
30
Veritas Investment Management (UK)
United Kingdom
$36K – – –
LTFS
31
Ladenburg Thalmann Financial Services
Florida
$29K +$14.5K +1,633 New
IA
32
IFP Advisors
Florida
$26K +$7.12K +800 +114%
DWA
33
Dorsey Wright & Associates
California
$20K +$10.3K +1,159 New
AG
34
Advisor Group
Arizona
$10K +$5.17K +580 New
Federated Hermes
35
Federated Hermes
Pennsylvania
$9K +$4.45K +500 New
TDC
36
Thompson Davis & Co
Virginia
$9K +$4.45K +500 New
Commonwealth Equity Services
37
Commonwealth Equity Services
Massachusetts
– -$76K -11,910 Closed
SSB
38
Sandy Spring Bank
Maryland
– -$53K -8,333 Closed
TRCT
39
Tower Research Capital (TRC)
New York
– -$11K -1,799 Closed
Royal Bank of Canada
40
Royal Bank of Canada
Ontario, Canada
– +$125 +14 New
1
2

CSBR Hedge Fund Activity: Q3 2018 in Review

37 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Champions Oncology (CSBR) for Q3 2018, worth a combined $100M — up 267% from $27.3M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new CSBR positions and 3 closed out — a net gain of 19 holders — while 8 added to existing stakes and 3 trimmed.

The largest buyer was EAM Investors, opening a new position worth an estimated $1.6M. The largest seller was Tocqueville Asset Management, cutting an estimated $226K.

  • 37 institutional investors held Champions Oncology (CSBR) as of Q3 2018, up from 18 in Q2 2018.
  • Funds reported $100M of Champions Oncology stock for Q3 2018, up 267% quarter-over-quarter.
  • 22 funds opened new Champions Oncology positions in Q3 2018 and 3 closed out, a net change of +19 holders.
  • The largest Champions Oncology buyer in Q3 2018 was EAM Investors, an estimated $1.6M added.
  • The largest Champions Oncology seller in Q3 2018 was Tocqueville Asset Management, an estimated $226K sold.

Based on aggregated 13F filings for Q3 2018.